Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-25T20:36:10.488Z Has data issue: false hasContentIssue false
  • English
  • Français

Fluoxetine and suicidal behaviour

Published online by Cambridge University Press:  02 January 2018

Debbie Harrison
Debbie Harrison*
Affiliation:
Lilly Industries Limited, Dextra Court, Chapel Hill, Basingstoke, Hampshire RG21 2SY
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 162 , Issue 3 , March 1993 , pp. 424
Copyright
Copyright © The Royal College of Psychiatrists 

References

Baldessarini, R. J., Marsh, E. R. & Kula, N. S. (1992) Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions. Brain Research, 579, 152—156.CrossRefGoogle ScholarPubMed
Committee on Safety of Medicines (1992) Safety of fluoxetine (Prozac): Comparison with fluvoxamine (Faverin). Current Problems (June).Google Scholar
Damluji, N. F. & Ferguson, J. M. (1988) Paradoxical worsening of depressive symptomatology caused by antidepressants. Journal of Clinical Psychopharmacology, 8, 347—349.Google Scholar
Kerr, J. S., Hindmarch, I. & Sherwood, N. (1991) The comparative psychopharmacology of 5-HT reuptake inhibitors. Human Psychopharmacology, 6, 313—317.Google Scholar
Price, J., et al (1992) Safety of fluoxetine: comparison with fluvoxamine. Pharmacoepidemiology and Drug Safety, 1, 111—117.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.